Central nervous system progression of me
β
Ronnie J. Freilich; Andrew D. Seidman; Dr. Lisa M. Deangelis
π
Article
π
1995
π
John Wiley and Sons
π
English
β 474 KB
π 2 views
Background. The possibility of tumor sanctuary sites in the central nervous system (CNS) of patients receiving paclitaxel has been suggested by laboratory data identifying low concentrations of drug in the brain and cerebrospinal fluid (CSF) of rats. Methods. The pattern of disease progression in p